Eva‐Maria Paulus

720 total citations
20 papers, 506 citations indexed

About

Eva‐Maria Paulus is a scholar working on Transplantation, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Eva‐Maria Paulus has authored 20 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Transplantation, 9 papers in Psychiatry and Mental health and 5 papers in Surgery. Recurrent topics in Eva‐Maria Paulus's work include Renal Transplantation Outcomes and Treatments (13 papers), Neurological Complications and Syndromes (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Eva‐Maria Paulus is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Neurological Complications and Syndromes (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Eva‐Maria Paulus collaborates with scholars based in Germany, Switzerland and Austria. Eva‐Maria Paulus's co-authors include B. Saletu, A. Neuhold, Frank Lehner, Claudia Sommerer, Klemens Budde, Wolfgang Arns, Christoph May, Oliver Witzke, Matúš Rehák and L Linzmayer and has published in prestigious journals such as Psychopharmacology, American Journal of Ophthalmology and Transplantation.

In The Last Decade

Eva‐Maria Paulus

20 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva‐Maria Paulus Germany	10	206	120	113	108	82	20	506
Ken Ohtsuka Japan	11	95 0.5×	169 1.4×	16 0.1×	33 0.3×	22 0.3×	15	482
David H. Rosenbaum United States	11	28 0.1×	176 1.5×	79 0.7×	6 0.1×	5 0.1×	18	391
Julie Craps Belgium	10	14 0.1×	48 0.4×	46 0.4×	9 0.1×	5 0.1×	13	332
Leona Fields United States	9	87 0.4×	56 0.5×	94 0.8×		19 0.2×	16	404
Jonathan M. Koff United States	9	40 0.2×	69 0.6×	18 0.2×		18 0.2×	13	387
Yu-Fan Cheng Taiwan	14	11 0.1×	127 1.1×	34 0.3×		82 1.0×	21	403
Adriana Pané Spain	11	26 0.1×	107 0.9×	29 0.3×	3 0.0×	4 0.0×	45	449
Agostinho Tavares Brazil	9	46 0.2×	70 0.6×	17 0.2×		8 0.1×	17	324
Xiaoqin Huang China	9	3 0.0×	33 0.3×	13 0.1×	7 0.1×	48 0.6×	28	379
Gyu Jeong Noh South Korea	8	8 0.0×	140 1.2×	13 0.1×	1 0.0×	52 0.6×	23	620

Countries citing papers authored by Eva‐Maria Paulus

Since Specialization

Citations

This map shows the geographic impact of Eva‐Maria Paulus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva‐Maria Paulus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva‐Maria Paulus more than expected).

Fields of papers citing papers by Eva‐Maria Paulus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva‐Maria Paulus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva‐Maria Paulus. The network helps show where Eva‐Maria Paulus may publish in the future.

Co-authorship network of co-authors of Eva‐Maria Paulus

This figure shows the co-authorship network connecting the top 25 collaborators of Eva‐Maria Paulus. A scholar is included among the top collaborators of Eva‐Maria Paulus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva‐Maria Paulus. Eva‐Maria Paulus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veelken, Roland, Karl F. Hilgers, Eva‐Maria Paulus, et al.. (2020). Afferent renal innervation in anti-Thy1.1 nephritis in rats. American Journal of Physiology-Renal Physiology. 319(5). F822–F832. 7 indexed citations

Hilgers, Karl F., Eva‐Maria Paulus, Gisa Tiegs, et al.. (2020). Neurogenic tachykinin mechanisms in experimental nephritis of rats. Pflügers Archiv - European Journal of Physiology. 472(12). 1705–1717. 6 indexed citations

Budde, Klemens, Martin Zeier, Oliver Witzke, et al.. (2017). Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial. Nephrology Dialysis Transplantation. 32(6). 1060–1070. 29 indexed citations

Hattenbach, Lars‐Olof, Nicolas Feltgen, Thomas Bertelmann, et al.. (2017). Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B). Acta Ophthalmologica. 96(1). e10–e18. 48 indexed citations

Hoerauf, Hans, Nicolas Feltgen, Claudia Weiß, et al.. (2016). Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study. American Journal of Ophthalmology. 169. 258–267. 61 indexed citations

Manger, Bernhard, Falk Hiepe, Peter Wimmer, et al.. (2015). Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study. Clinical and Experimental Gastroenterology. 8. 205–205. 12 indexed citations

Sterneck, Martina, Utz Settmacher, Tom M. Ganten, et al.. (2014). Improvement in Gastrointestinal and Health-related Quality of Life Outcomes After Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Liver Transplant Recipients. Transplantation Proceedings. 46(1). 234–240. 12 indexed citations

Sterneck, Martina, Gernot Kaiser, Nils Heyne, et al.. (2014). Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation. American Journal of Transplantation. 14(3). 701–710. 68 indexed citations

Lehner, Frank, Claudia Sommerer, Wolfgang Arns, et al.. (2014). Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen.. Transplantation. 98. 613–613. 1 indexed citations

10.

Budde, Klemens, Wolfgang Arns, Claudia Sommerer, et al.. (2014). Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: Follow-Up of the HERAKLES Study at Month 36.. Transplantation. 98. 81–81. 6 indexed citations

11.

Arns, Wolfgang, Timo Räth, Claudia Sommerer, et al.. (2014). Outcome On Renal Function of an Everolimus Based Therapy After Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 5 Year Data of the APOLLO Trial.. Transplantation. 98. 145–145. 2 indexed citations

12.

Arns, Wolfgang, Claudia Sommerer, Petra Glander, et al.. (2013). A randomized trial of intensified vs. standard dosing for enteric-coated mycophenolate sodium in de novo kidney transplant recipients: results at 1 year. Clinical Nephrology. 79(6). 421–431. 6 indexed citations

13.

Räth, Timo, Klemens Budde, Claudia Sommerer, et al.. (2012). Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial. Transplantation. 94(10S). 994–994. 2 indexed citations

14.

Budde, Klemens, Frank Lehner, Claudia Sommerer, et al.. (2012). Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study. American Journal of Transplantation. 12(6). 1528–1540. 70 indexed citations

15.

Arns, Wolfgang, Claudia Sommerer, Oliver Witzke, et al.. (2012). Efficacy and Safety of Three Different Treatment Regimens in de Novo Renal Transplant Patients: Results of the HERAKLES Trial. Transplantation. 94(10S). 995–995. 4 indexed citations

16.

Witzke, Oliver, Frank Lehner, Wolfgang Arns, et al.. (2012). Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in de Novo Renal Transplant Patients: 4 Years Follow-Up of the ZEUS Trial. Transplantation. 94(10S). 993–993. 3 indexed citations

17.

Witzke, Oliver, Klemens Budde, Frank Lehner, et al.. (2012). Superior Renal Function in an Everolimus-Based Calcineurin Inhibitor Free Regimen Compared to Standard Cyclosporine/Mycophenolate and Low Cyclosporine/Everolimus: The HERAKLES Study. Transplantation. 94(10S). 993–993. 4 indexed citations

18.

Kees, Martin G., Thomas Steinke, Stefan Moritz, et al.. (2011). Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric‐Coated Mycophenolate Sodium in Healthy Volunteers. The Journal of Clinical Pharmacology. 52(8). 1265–1272. 39 indexed citations

19.

Saletu, B., Eva‐Maria Paulus, L Linzmayer, et al.. (1995). Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology. 117(4). 385–395. 67 indexed citations

20.

Saletu, B., et al.. (1991). EEG Brain Mapping in Diagnostic and Therapeutic Assessment of Dementia. Alzheimer Disease & Associated Disorders. 5. S57–S75. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact